安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Claiming Akebia agreement breach, Otsuka seeks to end anemia . . .
Otsuka Pharmaceutical is ending its alliance with Akebia Therapeutics, a move that comes less than two months after the FDA rejected their partnered anemia drug, vadadustat, and asked for another
- SHAREHOLDER ALERT: Purcell Julie Lefkowitz LLP Is . . .
NEW YORK, April 26, 2021 PRNewswire -- Purcell Julie Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of
- Akebia Therapeutics, Inc. Vs. Us Data Management, Llc
On January 20, 2017, Akebia Therapeutics, Inc filed a Breach of Contract - (Commercial) case represented by Zakarian, Esq , Dana A against Us Data Management, Llc respresented by Messenger, Esq , James L et al in the jurisdiction of Middlesex County, MA
- Akebia Therapeutics: FDA Approval Failure, Terminated . . .
Otsuka Pharmaceuticals terminated collaboration with AKBA and is alleging material breaches The CRLs delivered by the FDA for Vadadustat significantly decrease the likelihood of the product's
- Bragar Eagel Squire, P. C. | Akebia Therapeutics, Inc.
Bragar Eagel Squire, P C , a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Akebia Therapeutics, Inc (“Akebia” or the “Company”) (NASDAQ: AKBA) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased
- Akebia Therapeutics, Inc. (NASDAQ:AKBA) Long Term Investor . . .
The investigation by a law firm for current long term investors in NASDAQ: AKBA stocks follows a lawsuit filed against Akebia Therapeutics, Inc over alleged securities laws violations
- Akebia Therapeutics, Inc. (AKBA) - Fields Kupka Shukurov LLP
Investor Alert: Fields Kupka Shukurov LLP is investigating breach of fiduciary duty claims involving the board of directors of Akebia Therapeutics, Inc (NASDAQ: AKBA)
|
|
|